Swine flu vaccines will not be foolproof: WHO

November 02, 2009 07:02 pm | Updated November 17, 2021 06:39 am IST - New Delhi

An Israeli medical worker displays ampoules with swine flu vaccine at the Ichilov hospital in Tel Aviv, Israel, Monday, Nov. 2, 2009. Israel has already ordered enough swine flu vaccine for 30 percent of its population even though it is still in development, according to the Health Ministry. Photo: Heidi Levine

An Israeli medical worker displays ampoules with swine flu vaccine at the Ichilov hospital in Tel Aviv, Israel, Monday, Nov. 2, 2009. Israel has already ordered enough swine flu vaccine for 30 percent of its population even though it is still in development, according to the Health Ministry. Photo: Heidi Levine

The much-awaited swine flu vaccine, currently being developed, will not provide 100 per cent protection against the disease, the World Health Organisation said.

“No vaccines, including pandemic influenza vaccines, provide 100 per cent protection against the disease. But they do greatly reduce the risk of disease,” WHO said in a statement, replying questions related to the vaccine.

According to the WHO, the influenza vaccines will become effective only 14 days after vaccination. Those infected shortly before one to three days or shortly after immunisation can still get the disease.

Moreover, the pandemic influenza vaccines are not expected to provide protection against other influenza virus.

“Since current seasonal influenza vaccines do not contain the pandemic virus, people should be vaccinated against both pandemic influenza and seasonal influenza.”

There are two types of vaccines - one contains killed viruses, which is given by injection into the upper arm for most people. For infants and young children, thigh is the preferred site for the vaccine shot. Another type of vaccine is made with live viruses and it is administered by nasal spray.

Recommendations on number of dosages to be used, is yet to be finalised. While immunisation experts recommend a single dose of vaccine in adults and adolescents from 10 years of age and above, more study is advised on effective dosage regimens for immuno-suppressed persons for whom two doses of vaccine may be needed, the WHO said.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.